When Severe GI Symptoms Aren't Always What They Seem: Could Alpha-gal Syndrome Be Mistaken for Cannabinoid Hyperemesis Syndrome?

For many patients, the path to a diagnosis is rarely straightforward. Symptoms such as nausea, vomiting, abdominal pain, diarrhea, weight loss, and dehydration can occur in a wide range of medical conditions. When those symptoms become severe enough to require emergency care, healthcare providers must often make decisions quickly using the information available at the time.

Recently, a family reached out to TickBiteData to share their experience navigating years of severe gastrointestinal illness, repeated emergency room visits, and difficulty obtaining answers. In addition to concerns about misdiagnosis, they described feeling dismissed and unsupported during interactions with the healthcare system. Their story raised an important question:

When two conditions share many of the same symptoms, how can patients and providers ensure that all reasonable possibilities are being considered?

The purpose of this article is not to challenge the legitimacy of Cannabinoid Hyperemesis Syndrome (CHS) or any other diagnosis. CHS is a recognized medical condition that affects some individuals who use cannabis regularly. Instead, this article explores the symptom overlap between CHS and Alpha-gal Syndrome (AGS) and asks whether Alpha-gal Syndrome is always being considered when patients present with recurring gastrointestinal symptoms.

What is Cannabinoid Hyperemesis Syndrome?

Cannabinoid Hyperemesis Syndrome is a condition associated with long-term cannabis use. Patients often experience recurring episodes of severe nausea, vomiting, abdominal pain, and dehydration. Many require multiple emergency room visits before receiving a diagnosis.

One of the hallmark features of CHS is that symptoms often improve with hot showers or baths, and many patients experience significant improvement after stopping cannabis use.

CHS is a real condition and can have a profound impact on quality of life. However, the symptoms that bring patients to the emergency room can look remarkably similar to symptoms reported by some Alpha-gal Syndrome patients.

What is Alpha-gal Syndrome?

Alpha-gal Syndrome is a tick-associated condition triggered by an immune response to a sugar molecule called galactose-α-1,3-galactose (alpha-gal), which is found in mammals and mammalian-derived products.

Although AGS is frequently described in the media as a "red meat allergy," patient experiences often extend far beyond a simple food allergy narrative.

In TickBiteData's patient-reported surveys, respondents commonly report:

• Nausea

• Vomiting

• Diarrhea

• Abdominal pain

• Brain fog

• Dizziness

• Rapid heart rate

• Anxiety

• Hives

• Swelling

• Anaphylaxis

Importantly, not every patient experiences the same symptoms, and not every reaction involves obvious hives or respiratory distress.

The Overlap

Consider the symptoms that frequently bring patients to the emergency room:

Symptom	CHS	AGS
Severe nausea	✓	✓
Recurrent vomiting	✓	✓
Abdominal pain	✓	✓
Diarrhea	✓	✓
Weight loss	✓	✓
Dehydration	✓	✓
Repeated ER visits	✓	✓

From a purely symptom-based perspective, there can be significant overlap.

A patient arriving in the emergency department actively vomiting may not be presenting with hives, facial swelling, or obvious signs of an allergic reaction. If cannabis use is identified during the medical history, CHS may understandably become part of the diagnostic discussion.

However, if that same patient has a history of tick exposure, delayed reactions after meals, unexplained allergic symptoms, reactions to dairy or gelatin, or episodes of anaphylaxis, Alpha-gal Syndrome may also deserve consideration.

Not Every Alpha-gal Patient Has Hives

One of the greatest challenges in Alpha-gal awareness is the assumption that every reaction looks like a traditional food allergy.

Many healthcare providers and patients alike associate food allergies with immediate hives, swelling, or breathing difficulties. While those symptoms can certainly occur in AGS, patient-reported data continue to demonstrate a broader clinical picture.

Some patients report gastrointestinal symptoms as their most prominent concern. Others describe years of digestive issues before Alpha-gal Syndrome was ever discussed.

This creates an important question:

If a patient repeatedly presents with severe gastrointestinal symptoms, but without obvious hives or breathing problems, how often is Alpha-gal Syndrome included in the differential diagnosis?

The Cost of Diagnostic Delays

One of the most consistent findings in TickBiteData's surveys is the length of time many patients spend searching for answers.

Among survey respondents:

• Nearly two-thirds report receiving one or more alternative diagnoses before receiving an Alpha-gal Syndrome diagnosis.

• Many report seeing multiple healthcare providers before AGS was considered.

• Some describe years of symptoms before obtaining an explanation.

These findings do not prove that any specific diagnosis was incorrect. Medicine is complex, and many conditions share overlapping symptoms.

However, they do highlight a broader issue: diagnostic delays can significantly affect quality of life, healthcare utilization, financial burden, and patient trust in the healthcare system.

When Patients Feel Dismissed

The challenge is not always the diagnosis itself.

For many patients, the most difficult part of their journey is feeling dismissed, stigmatized, or unsupported while seeking care.

Stories shared with TickBiteData frequently include experiences such as:

• Being told symptoms were anxiety-related.

• Being advised that reactions to certain foods or products were impossible.

• Having concerns minimized despite repeated symptoms.

• Struggling to find providers familiar with Alpha-gal Syndrome.

Regardless of the final diagnosis, patients deserve respectful, evidence-based care and a thorough evaluation of their symptoms.

When individuals feel unheard, trust in the healthcare system can erode. Some patients report avoiding future medical care altogether because of previous negative experiences.

That outcome benefits no one.

A Public Health Question Worth Asking

This discussion is not about choosing between Cannabinoid Hyperemesis Syndrome and Alpha-gal Syndrome.

Both conditions are real.

Both can significantly impact patients and families.

The question is whether patients presenting with recurring gastrointestinal symptoms are receiving a comprehensive evaluation that considers all reasonable possibilities.

As Alpha-gal Syndrome continues to expand geographically and awareness grows among healthcare professionals, it may become increasingly important to consider AGS alongside other conditions that produce similar gastrointestinal symptoms.

The Bottom Line

Cannabinoid Hyperemesis Syndrome and Alpha-gal Syndrome can share many of the same gastrointestinal symptoms, including nausea, vomiting, abdominal pain, diarrhea, dehydration, and repeated emergency room visits.

That overlap does not mean the conditions are the same.

It does mean that symptom-based diagnosis can be challenging, particularly when Alpha-gal Syndrome is not yet on a provider's radar.

For patients and families navigating unexplained gastrointestinal illness, awareness matters.

For healthcare providers, asking the right questions matters.

And for the broader medical community, continuing to improve recognition of the full spectrum of Alpha-gal Syndrome may help shorten the diagnostic journey for future patients and families.

TickBiteData.com collects patient-reported information to identify emerging patterns, healthcare challenges, and quality-of-life impacts associated with Alpha-gal Syndrome. Findings are intended to support awareness and generate discussion and should not be interpreted as medical advice or population-level prevalence estimates.